CSF2 and breast carcinoma: In accordance with their poorer differentiation into Mo-DCs, peripheral blood mononuclear cells obtained from breast cancer patients showed lower levels of GM-CSF (CD116) and IL-4 receptor (CD124) expression than healthy donors' cells (Figures 3(a) and 3(b)).